Trial · NCT01206062
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With First Occurrence of a Myocardial Infarction (MI), Acute Coronary Syndrome (ACS), Stroke, Heart Failure (HF), or CVD Death | Intensive Control of SBP | 243 | Participants | ||
| Number of Participants With First Occurrence of a Myocardial Infarction (MI), Acute Coronary Syndrome (ACS), Stroke, Heart Failure (HF), or CVD Death | Standard Control of SBP | 319 | Participants | ||
| Number of Participants With All-cause Mortality | Intensive Control of SBP | 155 | Participants | ||
| Number of Participants With All-cause Mortality | Standard Control of SBP | 210 | Participants | ||
| Number of CKD Participants Who Experienced a 50% Decline From Baseline eGFR | Intensive Control of SBP | 10 | Participants | ||
| Number of CKD Participants Who Experienced a 50% Decline From Baseline eGFR | Standard Control of SBP | 12 | Participants | ||
| Participants Who Developed End Stage Renal Disease | Intensive Control of SBP | 12 | Participants | ||
| Participants Who Developed End Stage Renal Disease | Standard Control of SBP | 8 | Participants | ||
| Number of Patients With All-cause Dementia | Intensive Control of SBP | 149 | Participants | ||
| Number of Patients With All-cause Dementia | Standard Control of SBP | 176 | Participants | ||
| Small Vessel Cerebral Ischemic Disease | Intensive Control of SBP | Change in total white matter lesion volume from ba | 0.23 | 95% Confidence Interval 0.17 to 0.29 | asinh(cm3) |
| Small Vessel Cerebral Ischemic Disease | Standard Control of SBP | Change in total white matter lesion volume from ba | 0.37 | 95% Confidence Interval 0.30 to 0.43 | asinh(cm3) |
| Small Vessel Cerebral Ischemic Disease | Intensive Control of SBP | Change in total brain volume from baseline | -7.7 | 95% Confidence Interval -8.1 to -7.3 | asinh(cm3) |
| Small Vessel Cerebral Ischemic Disease | Standard Control of SBP | Change in total brain volume from baseline | -6.8 | 95% Confidence Interval -7.3 to -6.3 | asinh(cm3) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01206062/results